Kinetic-controlled hydrolysis of Leu-Val-Val-hemorphin-7 catalyzed by angiotensin-converting enzyme from rat brain

Peptides

Volumn 24, Issue 7, 2003, Pages 1075-1082

  Hayakari, Makoto ^a   Satoh, Kimihiko ^b   Izumi, Hiroshi ^c   Kudoh, Toshihiro ^a   Asano, Junpei ^a   Yamazaki, Takehiko ^a   Tsuchida, Shigeki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Angiotensin converting enzyme; Hemorphin; LVV hemorphin 7; Opioid peptide

Indexed keywords

ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE; LEUCYLVALYLVALYLHEMORPHIN 7; OPIATE PEPTIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; EVALUATION; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; QUANTITATIVE ANALYSIS; RAT;

FELIS CATUS;

EID: 0141629603     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(03)00178-5     Document Type: Article

References (24)

1. Bernstein K.E., Martin B.M., Edwards A.S., Bernstein E.A. Mouse angiotensin-converting enzyme is a protein composed of two homologous domains. J. Biol. Chem. 264:1989;11945-11951.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;245-248.
3. Deddish P.A., Marcic B., Jackman H.L., Wang H.Z., Skidgel R.A., Erdös E.G. N-Domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension. 31:1998;912-917.
4. Ehlers M.R., Fox E.A., Strydom D.J., Riordan J.F. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7741-7745.
5. Erdös E.G. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension. 16:1990;363-370.
6. Fernandez M., Liu X., Wouters M.A., Heyberger S., Husain A. Angiotensin I-converting enzyme transition state stabilization by his 1089. Evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases. J. Biol. Chem. 276:2001;4998-5004.
7. Hayakari M., Seito R., Furugori A., Hashimoto Y., Murakami S. An improved colorimetric assay of angiotensin-converting enzyme in serum. Clin. Chim. Acta. 144:1984;71-75.
8. Hayakari M., Satoh K., Ookawa K., Kano H., Murakami S., Ikeda N.et al. Kinetic evaluation of β-neoendorphin hydrolysis by the somatic and testicular isozyme of human angiotensin-converting enzyme. Biochim. Biophys. Acta. 1339:1997;31-38.
9. Hirawa N., Uehara Y., Kawabata Y., Numabe A., Gomi T., Ikeda T.et al. Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. Hypertension. 34:1999;496-502.
10. Hubert C., Houot A.M., Corvol P., Soubrier F. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J. Biol. Chem. 266:1991;15377-15383.
11. Jaspard E., Wei L., Alhenc-Gelas F. Differences in the properties and enzymatic specificities of two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J. Biol. Chem. 268:1993;9496-9503.
12. Kumar R.S., Kusari J., Roy S.N., Soffer R.L., Sen G.C. Structure of testicular angiotensin-converting enzyme. A segmental mosaic isozyme. J. Biol. Chem. 264:1989;16754-16758.
13. Lattion A.L., Soubrier F., Allegrini J., Hubert C., Corvol P., Alhenc-Gelas F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett. 252:1989;99-104.
14. Lord J.A., Watefield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 267:1977;495-499.
15. Moeller I., Lew R.A., Mendelsohn F.A., Smith A.I., Brennan M.E., Tetaz T.J.et al. The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain. J. Neurochem. 68:1997;2530-2537.
16. Mondadori C., Hengerer B., Ducret T., Borkowski J. Delayed emergence of effects of memory-enhancing drugs: implications for the dynamics of long-term memory. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2041-2045.
17. Nyberg F., Sanderson K., Glamsta E.L. The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin. Biopolymers. 43:1997;147-156.
18. Rousseau A., Michaud A., Chauvet M.T., Lenfant M., Corvol P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J. Biol. Chem. 270:1995;3656-3661.
19. Soubrier F., Alhenc-Gelas F., Hubert C., Allegrini J., John M., Tregear G.et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. U.S.A. 85:1988;9386-9390.
20. Wei L., Alhenc-Gelas F., Corvol P., Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266:1991;9002-9008.
21. Yatskin O.N., Philippova M.M., Blishchenko E.Y., Karelin A.A., Ivanov V.T. LVV- and VV-hemorphins: comparative levels in rat tissues. FEBS Lett. 428:1998;286-290.
22. Yodaft Y., Bar-On D., Amir M., Cristal N. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study. J. Hum. Hypertens. 10:1996;117-122.
23. Zhao Q., Sannier F., Garreau I., Guillochon D., Piot J.M. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate. Biochem. Biophys. Res. Commun. 204:1994;216-223.
24. Zhao Q., Piot J.M. Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin. Neuropeptides. 31:1997;147-153.